Improved Gas Transfer in Phase III aPAP Trial – European Medical Journal Improved Gas Transfer in Phase III aPAP Trial
INHALED therapy improved gas transfer and respiratory health in adults with autoimmune pulmonary alveolar proteinosis. Autoimmune pulmonary alveolar proteinosis is a rare lung disease in which surfactant accumulates in the…
Savara’s PAP Drug Shows 9.8% Lung Function Gain in Phase 3 Trial
08/20/2025 – 05:15 PM — In the Largest Clinical Trial…